ArticleInternational journal of clinical oncology2026
The changes of CD47 and PD-L1 (SP142) before and after neoadjuvant therapy help predict prognosis of patients with stage IIIA-N2 non-small cell lung cancer.
Qichang Jiang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.